OR52T1P

Across TCGA pan-cancer cohorts, OR52T1P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR52T1P’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where OR52T1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR52T1P is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LUSC, BRCA, and KICH are the cancer types where OR52T1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52T1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	−0.029	.025	3	view →
BRCA	All	All	+0.112	.035	2	view →
KICH	Male	II,III,IV	−0.053	.030	2	view →
THCA	All	All	−0.039	.017	2	view →
KIRC	Male	All	+0.020	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR52T1P–LUSC

Open the LUSC breakdown →